{"SPADE_UN_17542": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_UN_17542", "Peptide Name": "Brevibacillin", "Source": "Synthetic", "Family": "", "Gene": "Not found", "Sequence": "XLXIIVKVVKYLX", "Sequence Length": 13, "UniProt Entry": ["http://www.uniprot.org/uniprot/Notavailable"], "Protein Existence": "Not found", "Biological Activity": ["Antimicrobial", "Anticancer"], "Target Organism": "Not available", "Hemolytic Activity": "Not available", "Cytotoxicity": "Not available", "Binding Target": "Not available", "Linear/Cyclic": "Linear", "N-terminal Modification": "2-OH-ME-C5", "C-terminal Modification": "Free", "Stereochemistry": "L", "Structure Description": "Not found", "Formula": "C60H100N12O9", "Mass": 167776, "PI": 10.25, "Net Charge": 2, "Hydrophobicity": 1.546, "Half Life": "Mammalian:/Yeast:/E.coli:/", "Literature": [{"Title": "Brevibacillin 2V, a Novel Antimicrobial Lipopeptide With an Exceptionally Low Hemolytic Activity", "Pubmed ID": "34220785", "Reference": "Front Microbiol. 2021 Jun 17;12693727.", "Author": "Zhao X, Wang X, Shukla R, Kumar R, Weingarth M, Breukink E, Kuipers OP.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=34220785"}], "Frequent Amino Acids": "VXI", "Absent Amino Acids": "ACDEFGHMNOPQRSTUW", "Basic Residues": 2, "Acidic Residues": 0, "Hydrophobic Residues": 8, "Polar Residues": 6, "Positive Residues": 2, "Negative Residues": 0, "Similar Sequences": [{"SPADE_ID": "SPADE_UN_05353", "Similarity": 1.0, "Sequence": "WYKKIRLII"}, {"SPADE_ID": "SPADE_UN_17542", "Similarity": 1.0, "Sequence": "LIIVKVVKYL"}, {"SPADE_ID": "SPADE_N_08685", "Similarity": 1.0, "Sequence": "VKYLEFKSESIKQVK"}]}}}